Tapinarof Cream 1% Once Daily: Disease Control Off Treatment and Minimal Disease Activity Through End of Remittive Period in a 1-year Trial
Main Article Content
Keywords
Tapinarof, Aryl Hydrocarbon Receptor Agonist, Remittive Effect, Efficacy, Long-term Therapy, Plaque Psoriasis, Topical
References
1. Nowowiejska J, et al. Dermatol Ther (Heidelb). 2022;12:385–406.
2. Langley RGB, et al. Ann Rheum Dis. 2005;64(suppl 2):ii18–23.
3. Bissonnette R, et al. J Am Acad Dermatol. 2021;84:1059–67.
4. Tian D, Lai Y. J Invest Dermatol. 2022;2:100116. https://doi.org/10.1016/j.xjidi.2022.100116.
5. Elmets CA, et al. J Am Acad Dermatol. 2021;84:432–70.
6. Dermavant Sciences. VTAMA (tapinarof) cream, 1%: US prescribing information. 2022. https://www.vtama.com/docs/DMVT_VTAMA_PI.pdf. Accessed November 2022.
7. Lebwohl MG, et al. N Engl J Med. 2021;385:2219–29.
8. Strober B, et al. J Am Acad Dermatol. 2022;87:800–6.
9. Fredriksson T, Pettersson U. Dermatologica. 1978;157:238–44.
10. Hongbo Y, et al. J Invest Dermatol. 2005;125:659–64.
11. Robbins K, et al. J Am Acad Dermatol. 2019;80:714–21.
2. Langley RGB, et al. Ann Rheum Dis. 2005;64(suppl 2):ii18–23.
3. Bissonnette R, et al. J Am Acad Dermatol. 2021;84:1059–67.
4. Tian D, Lai Y. J Invest Dermatol. 2022;2:100116. https://doi.org/10.1016/j.xjidi.2022.100116.
5. Elmets CA, et al. J Am Acad Dermatol. 2021;84:432–70.
6. Dermavant Sciences. VTAMA (tapinarof) cream, 1%: US prescribing information. 2022. https://www.vtama.com/docs/DMVT_VTAMA_PI.pdf. Accessed November 2022.
7. Lebwohl MG, et al. N Engl J Med. 2021;385:2219–29.
8. Strober B, et al. J Am Acad Dermatol. 2022;87:800–6.
9. Fredriksson T, Pettersson U. Dermatologica. 1978;157:238–44.
10. Hongbo Y, et al. J Invest Dermatol. 2005;125:659–64.
11. Robbins K, et al. J Am Acad Dermatol. 2019;80:714–21.